Abstract
Background
We aimed to evaluate comparative outcomes of robotic and laparoscopic total mesorectal excision (TME) in patients with rectal cancer.
Methods
We systematically searched electronic data sources with application of combination of free text and controlled vocabulary search adapted to thesaurus headings, search operators, and limits. Perioperative clinical and short-term oncological outcomes were evaluated. Trial Sequential Analysis of the outcomes was conducted.
Results
Nine randomised-controlled trials reporting 1463 patients evaluating outcomes of robotic TME (n = 728) and laparoscopic TME (n = 735) were included. Although the robotic approach was associated with significantly longer operative time (MD 31.64, P = 0.002), it was associated with significantly longer DRM (MD 0.8, P = 0.004) and shorter time to soft diet (MD − 0.50, P = 0.03) compared to the laparoscopic approach. Moreover, there was no significant difference in intraoperative (RR 1.07, P = 0.76)) and postoperative (RR 0.97, P = 0.81) complications, anastomotic leak (RR 0.93, P = 0.69), conversion to open rate (RR 0.46, P = 0.05), blood loss (MD 19.65, P = 0.74), time to first flatus (MD − 0.30, P = 0.37), LARS (RR 0.83, P = 0.41), ileus (RR 0.72, P = 0.39), positive CRM (RR 0.82, P = 0.49), PRM (MD − 0.5, P = 0.55), number of harvested lymph nodes (MD 0.33, P = 0.58), or length of stay (MD − 0.60, P = 0.12) between two groups. The Trial Sequential Analysis demonstrated that the risk of type 1 and type 2 errors was minimal in most outcomes.
Conclusions
Moderate-quality evidence suggested that robotic and laparoscopic TME may be comparable in terms of clinical and short-term oncological profile but the robotic approach may be associated with longer procedure time. Future high-quality randomised studies are encouraged to compare the functional, long-term oncological, and cost-effectiveness outcomes of both approaches.
Similar content being viewed by others
Availability of data and material
We declare that this manuscript of meta-analysis and trial sequential analysis is original, has not been published before, and is not currently being considered for publication elsewhere. We confirm that the paper is not based on previous communication to a society or meeting.
References
Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL (2010) Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer 116:4354–4359
Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 133:894–899
Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O'Callaghan C, Myint AS, Bessell E, Thompson LC, Parmar M, Stephens RJ, Sebag-Montefiore D, MRC CR07/NCIC-CTG CO16 Trial Investigators, NCRI Colorectal Cancer Study Group (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821–828
Martling A, Singnomklao T, Holm T, Rutqvist LE, Cedermark B (2004) Prognostic significance of both surgical and pathological assessment of curative resection for rectal cancer. Br J Surg 91:1040–1045
Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas M, de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J, Angenete E, Rosenberg J, Fuerst A, Haglind E, COLOR II Study Group (2015) COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 372(14):1324–1332
Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, Choi HS, Kim DW, Chang HJ, Kim DY, Jung KH, Kim TY, Kang GH, Chie EK, Kim SY, Sohn DK, Kim DH, Kim JS, Lee HS, Kim JH, Oh JH (2014) Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 15(7):767–774
Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J, ALaCaRT Investigators (2015) ALaCaRT Investigators. Effect of laparoscopic assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314(13):1356–1363
Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PWT, Nelson H (2015) Effect of laparoscopic-assisted resection versus open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314(13):1346–1355
Xiong B, Ma L, Huang W, Zhao Q, Cheng Y, Liu J (2015) Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of eight studies. J Gastrointest Surg 19(3):516–526. https://doi.org/10.1007/s11605-014-2697-8
Prete FP, Pezzolla A, Prete F, Testini M, Marzaioli R, Patriti A, Jimenez-Rodriguez RM, Gurrado A, Strippoli GFM (2018) Robotic versus laparoscopic minimally invasive surgery for rectal cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Surg 267(6):1034–1046
Kowalewski KF, Seifert L, Ali S, Schmidt MW, Seide S, Haney C, Tapking C, Shamiyeh A, Kulu Y, Hackert T, Müller-Stich BP, Nickel F (2020) Functional outcomes after laparoscopic versus robotic-assisted rectal resection: a systematic review and meta-analysis. Surg Endosc. https://doi.org/10.1007/s00464-019-07361-1
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700
Higgins JP, Altman DG, Editors Chapter 8 (2018) Assessing risk of bias in included studies. In: Higgins JP, Green S, editors. Cochrane handbook for systemic reviews of interventions. Version 5.0.1 [updated September 2008]. Available at: http://hiv.cochrane.org/sites/hiv.cochrane.org/files/uploads/Ch08 Bias.pdf. Accessed November 28
Patriti A, Ceccarelli G, Bartoli A, Spaziani A, Biancafarina A, Casciola L (2009) Short- and medium-term outcome of robot-assisted and traditional laparoscopic rectal resection. JSLS 13:176–183
Baik SH, Kwon HY, Kim JS, Hur H, Sohn SK, Cho CH, Kim H (2009) Robotic versus laparoscopic low anterior resection of rectal cancer: short-term outcome of a prospective comparative study. Ann Surg Oncol 16:1480–1487
Rodrıguez J, José M et al (2011) Prospective randomised study: robotic-assisted versus conventional laparoscopic surgery in colorectal cancer resection. Cir Esp 89(7):432–438
Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi PP, Edlin R, Hulme C, Brown J (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer The ROLARR Randomized Clinical Trial. JAMA 318(16):1569–1580
Kim MJ, Park SC, Park JW et al (2018) Robot-assisted versus laparoscopic surgery for rectal cancer A, Phase II open label prospective randomized controlled trial. Ann Surg 267(2):243–251. https://doi.org/10.1097/SLA.000000000000232
Tolstrup R, Funder JA, Lundbech L et al (2018) Perioperative pain after robot-assisted versus laparoscopic rectal resection. Int J Colorectal Dis 33:285–920
Xu J, Wei Y, Ren L et al (2017) Robot-assisted vs laparoscopic vs open abdominoperineal resections for low rectal cancer: short-term outcomes of a single-center prospective randomized controlled trial. Ann Oncol 28(5):158–208
Wang G, Wang Z, Jiang Z, Liu J, Zhao J, Li J (2017) Male urinary and sexual function after robotic pelvic autonomic nerve-preserving surgery for rectal cancer. Int J Med Robotics Comput Assist Surg 13:e1725
Debakey Y, Zaghloul A, Farag A et al (2018) Robotic-assisted versus conventional laparoscopic approach for rectal cancer surgery, First Egyptian Academic Center Experience, RCT. Minim Invasive Surg 2018:1-11 . https://doi.org/10.1155/2018/5836562
Hozo S, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13
Author information
Authors and Affiliations
Contributions
Conception and design: Mokhtar E, Shahin H
Literature search and study selection: Mokhtar E, Shahin H, Shahab H
Data collection: Mokhtar E, Shahin H, Shahab H
Analysis and interpretation: Mokhtar E, Shahin H, Shahab H
Writing the article: Mokhtar E, Shahin H, Shahab H
Critical revision of the article: All authors
Final approval of the article: All authors
Corresponding author
Ethics declarations
Competing interests
The authors declare that there are no conflicts of interest.
Code availability
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 63 kb)
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Eltair, M., Hajibandeh, S., Hajibandeh, S. et al. Meta-analysis and trial sequential analysis of robotic versus laparoscopic total mesorectal excision in management of rectal cancer. Int J Colorectal Dis 35, 1423–1438 (2020). https://doi.org/10.1007/s00384-020-03655-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-020-03655-2